Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data-Reference-Cited by-同舟云学术

Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data

Published:2014-07-05 Issue:3 Volume:35 Page:860-869
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Kim Hae Rim¹,Yim Hyung Joon¹,Kang Seonghee¹,Suh Sang Jun¹,Kim Seung Young¹,Hyun Jong Jin¹,Koo Ja Seol¹,Kim Ji Hoon¹,Seo Yeon Seok¹,Yeon Jong Eun¹,Lee Sang Woo¹,Byun Kwan Soo¹,Um Soon Ho¹

Affiliation:

1. Department of Internal Medicine; Korea University College of Medicine; Seoul Korea

Funder

Ministry of Health and Welfare

Yuhan corp

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12605/fullpdf

Reference24 articles.

1. Viral hepatitis B;Lai;Lancet,2003

2. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan;Chen;JAMA,1996

3. Current status of liver diseases in Korea: hepatitis B;Chae;Korean J Hepatol,2009

4. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load;Iloeje;Gastroenterology,2006

5. Telbivudine versus lamivudine in patients with chronic hepatitis B;Lai;N Engl J Med,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease;Hepatology International;2022-09-09

2. Clinical effects of NTCP‐inhibitor myrcludex B;Journal of Viral Hepatitis;2021-02-28

3. Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review;Journal of Gastroenterology;2020-03-17

4. Pathological changes of liver one year later in CHB patients with negative HBV DNA;Infectious Agents and Cancer;2019-12

5. Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis;PLOS ONE;2019-11-26